# Pfizer Inc.

Type: Company (PFE)

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/pfizer-inc
Canonical HTML page: https://getbiobrief.com/entity/pfizer-inc

## Recent coverage (1 stories)

### Pfizer's $12.7B Cash Cushion Backs 6% Dividend—R&D Tradeoff Looms
2026-09-13 00:27:27 · Sentiment: Neutral · Impact: 5/10 · Sources: 3

Pfizer paid $4.9B in dividends during H1 2026, backed by $12.7B in cash and short-term investments. While the cash dividend payout ratio is roughly 90%, biopharma investors may weigh this against pipeline and M&A capital needs.
Full story: https://getbiobrief.com/story/pfizer-dividend-biopharma-capital-tradeoff

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.